Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/34jQu2Q
via IFTTT